Blueprint Medicines Corp. (BPMC)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Blueprint Medicines Corp. (BPMC)
Go deeper and ask any question about BPMC
Company Performance
Current Price
as of Sep 18, 2024$89.33
P/E Ratio
N/A
Market Cap
$5.66B
Description
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Metrics
Overview
- HQCambridge, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerBPMC
- Price$89.33+3.26%
Trading Information
- Market Cap$5.66B
- Float98.25%
- Average Daily Volume (1m)540,741
- Average Daily Volume (3m)688,783
- EPS-$3.37
Company
- Revenue$362.80M
- Rev Growth (1yr)139.98%
- Net Income-$49.99M
- Gross Margin91.89%
- EBITDA Margin-28.54%
- EBITDA-$39.43M
- EV$6.75B
- EV/Revenue18.61
- P/EN/A
- P/S15.48
Documents
SEC Filings
Factset Street Account
Earnings Calls
Factset